Tonix Prescribed drugs Holding Corp. TNXP shares are transferring greater on Friday after the corporate supplied preliminary 2024 fiscal-year monetary outcomes.
What To Know: The corporate reported internet income of $10.1 million, in comparison with $7.8 million for the prior yr. As well as, it reported $98.8 million in money and money equivalents as of the top of 2024.
Tonix expects its money reserves, together with roughly $30.4 million in gross proceeds from 2025 first-quarter gross sales, to maintain operations by means of the 2026 first quarter. The money runway is anticipated to cowl operations previous the Meals and Drug Administration’s August fifteenth objective date for a call on advertising authorization for TNX-102 SL for fibromyalgia administration. The corporate is now debt-free after repaying a mortgage with JGB Capital on February 3.
Moreover, it reported capital expenditures of $0.1 million, in contrast $29.1 million for the prior yr.
Lastly, Tonix reported a internet working lack of $126.6 million, in comparison with a internet working lack of $116.7 million for the prior yr.
See Additionally: Client Sentiment Sinks In February: Economist Flags ‘Unusually Giant’ Rise In Inflation Notion
TNXP Worth Motion: On the time of writing, Tonix shares are buying and selling 14.8% greater at $12.90, per knowledge from Benzinga Professional.
Picture: through Shutterstock
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
